214 related articles for article (PubMed ID: 33221263)
1. Optimal Medical Therapy Following Transcatheter Aortic Valve Implantation.
Kaewkes D; Ochiai T; Flint N; Patel V; Mahani S; Kim I; Patel D; Salseth T; Friedman M; Yoon SH; Singh S; Chakravarty T; Nakamura M; Cheng W; Makkar R
Am J Cardiol; 2021 Feb; 141():62-71. PubMed ID: 33221263
[TBL] [Abstract][Full Text] [Related]
2. Renin-angiotensin system blockade therapy after transcatheter aortic valve implantation.
Ochiai T; Saito S; Yamanaka F; Shishido K; Tanaka Y; Yamabe T; Shirai S; Tada N; Araki M; Naganuma T; Watanabe Y; Yamamoto M; Hayashida K
Heart; 2018 Apr; 104(8):644-651. PubMed ID: 28986405
[TBL] [Abstract][Full Text] [Related]
3. Effects of renin-angiotensin system inhibitor type and dosage on survival after transcatheter aortic valve implantation.
Fischer-Rasokat U; Bänsch C; Renker M; Rolf A; Charitos EI; Weferling M; Liebetrau C; Herrmann E; Choi YH; Hamm CW; Kim WK
Eur Heart J Cardiovasc Pharmacother; 2022 Dec; 8(8):815-824. PubMed ID: 35441662
[TBL] [Abstract][Full Text] [Related]
4. The Impact of Left Ventricular Diastolic Dysfunction on Clinical Outcomes After Transcatheter Aortic Valve Replacement.
Asami M; Lanz J; Stortecky S; Räber L; Franzone A; Heg D; Hunziker L; Roost E; Siontis GC; Valgimigli M; Windecker S; Pilgrim T
JACC Cardiovasc Interv; 2018 Mar; 11(6):593-601. PubMed ID: 29501544
[TBL] [Abstract][Full Text] [Related]
5. Renin-angiotensin system inhibition is not associated with increased sudden cardiac death, cardiovascular mortality or all-cause mortality in patients with aortic stenosis.
Bang CN; Greve AM; Køber L; Rossebø AB; Ray S; Boman K; Nienaber CA; Devereux RB; Wachtell K
Int J Cardiol; 2014 Aug; 175(3):492-8. PubMed ID: 25012498
[TBL] [Abstract][Full Text] [Related]
6. Impact of renin-angiotensin system inhibitors on outcomes after surgical or transcatheter aortic valve replacement. A meta-analysis.
Amat-Santos IJ; Santos-Martínez S; Julca F; Catalá P; Rodríguez-Gabella T; Redondo-Diéguez A; Hinojosa W; Veras C; Campo A; Serrador Frutos A; Carrasco-Moraleja M; San Román JA
Rev Esp Cardiol (Engl Ed); 2021 May; 74(5):421-426. PubMed ID: 32402685
[TBL] [Abstract][Full Text] [Related]
7. The Association Between Beta-blocker and Renin-Angiotensin System Inhibitor Use After Heart Failure With Reduced Ejection Fraction Hospitalization and Outcomes in Older Patients.
Gilstrap L; Solomon N; Chiswell K; James O'Malley A; Skinner JS; Fonarow GC; Bhatt DL; Yancy CW; Devore AD
J Card Fail; 2023 Apr; 29(4):434-444. PubMed ID: 36516937
[TBL] [Abstract][Full Text] [Related]
8. Association of Renin-Angiotensin Inhibitor Treatment With Mortality and Heart Failure Readmission in Patients With Transcatheter Aortic Valve Replacement.
Inohara T; Manandhar P; Kosinski AS; Matsouaka RA; Kohsaka S; Mentz RJ; Thourani VH; Carroll JD; Kirtane AJ; Bavaria JE; Cohen DJ; Kiefer TL; Gaca JG; Kapadia SR; Peterson ED; Vemulapalli S
JAMA; 2018 Dec; 320(21):2231-2241. PubMed ID: 30512100
[TBL] [Abstract][Full Text] [Related]
9. Outcomes of Patients with Severe Aortic Stenosis and Left Ventricular Obstruction Undergoing Transcatheter Aortic Valve Implantation.
Kaewkes D; Ochiai T; Flint N; Patel V; Mahani S; Raschpichler M; Yoon SH; Skaf S; Singh S; Chakravarty T; Nakamura M; Cheng W; Makkar R
Am J Cardiol; 2020 Oct; 133():105-115. PubMed ID: 32811649
[TBL] [Abstract][Full Text] [Related]
10. Heart failure oral therapies at discharge are associated with better outcome in acute heart failure: a propensity-score matched study.
Gayat E; Arrigo M; Littnerova S; Sato N; Parenica J; Ishihara S; Spinar J; Müller C; Harjola VP; Lassus J; Miró Ò; Maggioni AP; AlHabib KF; Choi DJ; Park JJ; Zhang Y; Zhang J; Januzzi JL; Kajimoto K; Cohen-Solal A; Mebazaa A;
Eur J Heart Fail; 2018 Feb; 20(2):345-354. PubMed ID: 28849606
[TBL] [Abstract][Full Text] [Related]
11. Impact of renin-angiotensin system blocker after aortic valve replacement-a systematic review and meta-analysis.
Zeng L; Li J; Yang J; Liao Y; Chen M
Ann Palliat Med; 2021 Feb; 10(2):1244-1252. PubMed ID: 33040553
[TBL] [Abstract][Full Text] [Related]
12. Meta-analysis of impact of renin-angiotensin system inhibitors on survival after transcatheter aortic valve implantation.
Takagi H; Kuno T; Hari Y; Nakashima K; Yokoyama Y; Ueyama H; Ando T;
Minerva Cardiol Angiol; 2021 Jun; 69(3):299-309. PubMed ID: 33703852
[TBL] [Abstract][Full Text] [Related]
13. Evidence-based pharmacotherapies used in the postdischarge phase are associated with improved one-year survival in senior patients hospitalized with heart failure.
Qin X; Hung J; Knuiman M; Teng TK; Briffa T; Sanfilippo FM
Cardiovasc Ther; 2018 Dec; 36(6):e12464. PubMed ID: 30126048
[TBL] [Abstract][Full Text] [Related]
14. Association between renin-angiotensin system inhibitor use and mortality/morbidity in elderly patients with heart failure with reduced ejection fraction: a prospective propensity score-matched cohort study.
Savarese G; Dahlström U; Vasko P; Pitt B; Lund LH
Eur Heart J; 2018 Dec; 39(48):4257-4265. PubMed ID: 30351407
[TBL] [Abstract][Full Text] [Related]
15. Angiotensin-converting enzyme inhibitor for post-transcatheter aortic valve implantation patients: study protocol for a multicenter randomized, open-label blinded endpoint control trial.
Liao YB; Xia C; Cheng Y; Li Q; Wei X; Ou Y; Chen F; Li Y; Liu Q; Xiong T; Zhao Z; Peng Y; Wei J; Feng Y; Chen M
Trials; 2021 Jul; 22(1):462. PubMed ID: 34275476
[TBL] [Abstract][Full Text] [Related]
16. Is the use of renin-angiotensin system inhibitors in patients with aortic valve stenosis safe and of prognostic benefit? A systematic review and meta-analysis.
Andersson C; Abdulla J
Eur Heart J Cardiovasc Pharmacother; 2017 Jan; 3(1):21-27. PubMed ID: 27615013
[TBL] [Abstract][Full Text] [Related]
17. Effect of Optimizing Guideline-Directed Medical Therapy Before Discharge on Mortality and Heart Failure Readmission in Patients Hospitalized With Heart Failure With Reduced Ejection Fraction.
Yamaguchi T; Kitai T; Miyamoto T; Kagiyama N; Okumura T; Kida K; Oishi S; Akiyama E; Suzuki S; Yamamoto M; Yamaguchi J; Iwai T; Hijikata S; Masuda R; Miyazaki R; Hara N; Nagata Y; Nozato T; Matsue Y
Am J Cardiol; 2018 Apr; 121(8):969-974. PubMed ID: 29477488
[TBL] [Abstract][Full Text] [Related]
18. Association between valvuloarterial impedance after transcatheter aortic valve implantation and 2-year mortality in elderly patients with severe symptomatic aortic stenosis: the OCEAN-TAVI registry.
Nagura F; Kataoka A; Hara M; Kozuma K; Watanabe Y; Nakashima M; Hioki H; Kawashima H; Nara Y; Shirai S; Tada N; Araki M; Naganuma T; Yamanaka F; Ueno H; Tabata M; Mizutani K; Higashimori A; Takagi K; Yamamoto M; Hayashida K;
Heart Vessels; 2019 Jun; 34(6):1031-1039. PubMed ID: 30599060
[TBL] [Abstract][Full Text] [Related]
19. Beta-Blocker and Renin-Angiotensin System Inhibitor Combination Therapy in Patients with Acute Myocardial Infarction and Prediabetes or Diabetes Who Underwent Successful Implantation of Newer-Generation Drug-Eluting Stents: A Retrospective Observational Registry Study.
Kim YH; Her AY; Jeong MH; Kim BK; Hong SJ; Kim S; Ahn CM; Kim JS; Ko YG; Choi D; Hong MK; Jang Y
J Clin Med; 2020 Oct; 9(11):. PubMed ID: 33120966
[TBL] [Abstract][Full Text] [Related]
20. Role of Guideline Directed Medical Therapy Doses and Optimization in Patients Hospitalized With Decompensated Systolic Heart Failure.
Grewal D; Partow-Navid R; Garcia D; Coney J; Fraser G; Stoletniy L; Sakr A; Parwani P; Abramov D
Am J Cardiol; 2021 Jul; 151():64-69. PubMed ID: 34167690
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
